BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23910933)

  • 21. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C.
    Rivero-Juarez A; Mira JA; Santos-Gil I; Lopez-Cortes LF; Girón-Gonzalez JA; Marquez M; Merino D; Tellez F; Caruz A; Pineda JA; Rivero A;
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):223-5. PubMed ID: 22966845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients].
    Girón-González JA; Márquez MJ; Márquez M; Corchado S; Soto MJ; Martín-Aspas A; Montes De Oca M; Guerrero F; Fernández-Gutiérrez C
    Enferm Infecc Microbiol Clin; 2012 Jan; 30(1):15-7. PubMed ID: 21908078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus load and survival among injection drug users in the United States.
    Hisada M; Chatterjee N; Kalaylioglu Z; Battjes RJ; Goedert JJ
    Hepatology; 2005 Dec; 42(6):1446-52. PubMed ID: 16317675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
    Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
    Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification.
    Gordon SC; Dailey PJ; Silverman AL; Khan BA; Kodali VP; Wilber JC
    Hepatology; 1998 Dec; 28(6):1702-6. PubMed ID: 9828238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Bhagat V; Foont JA; Schiff ER; Regev A
    Liver Transpl; 2008 Jan; 14(1):92-5. PubMed ID: 18161776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
    AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
    Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D;
    HIV Med; 2013 Aug; 14(7):430-6. PubMed ID: 23461846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
    Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
    J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.
    Seal KH; Monto A; Dove L; Shen H; Vittinghoff E; Tracy D; Miller E; Lau E; Wright TL
    Dig Dis Sci; 2007 Dec; 52(12):3423-30. PubMed ID: 17443407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.
    Antonucci G; Vairo F; Iacomi F; Comandini UV; Solmone M; Piselli P; Boumis E; Lauria FN; Capobianchi MR; Ippolito G; Puro V
    Scand J Infect Dis; 2008; 40(11-12):928-34. PubMed ID: 18651264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
    Rohrbach J; Robinson N; Harcourt G; Hammond E; Gaudieri S; Gorgievski M; Telenti A; Keiser O; Günthard HF; Hirschel B; Hoffmann M; Bernasconi E; Battegay M; Furrer H; Klenerman P; Rauch A;
    Gut; 2010 Sep; 59(9):1252-8. PubMed ID: 20660698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
    Ramos-Casals M; Forns X; Brito-Zerón P; Vargas A; Ruiz M; Laguno M; Yagüe J; Sánchez-Tapias JM; Gatell JM; Font J
    J Viral Hepat; 2007 Oct; 14(10):736-42. PubMed ID: 17875009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
    Alidjinou EK; Moukassa D; Ebatetou-Ataboho E; Mahoungou GH; Pambou JP; Sané F; Prevost B; Bocket L; Ibara JR; Hober D
    J Infect Dev Ctries; 2014 Aug; 8(8):1068-71. PubMed ID: 25116677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.
    Vispo E; Barreiro P; Plaza Z; Fernández-Montero JV; Labarga P; de Mendoza C; Sierra-Enguita R; Treviño A; Lopez M; Soriano V
    AIDS; 2014 Jun; 28(10):1473-8. PubMed ID: 24637541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection.
    Wang CC; Morishima C; Chung M; Engelberg R; Krantz E; Krows M; Sullivan DG; Gretch DR; Corey L
    J Infect Dis; 2006 Mar; 193(5):672-6. PubMed ID: 16453262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.